Multifunctional Smart Yolk-Shell Nanostructure with Mesoporous MnO₂ Shell for Enhanced Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Manganese dioxide (MnO2) nanostructures are promising tumor microenvironment (TME)-responsive nanomaterials.
• Synthesizing yolk-shell nanostructures (YSNs) with mesoporous MnO2 shells presents significant challenges.

Purpose of the Study:

• To develop a novel yolk-shell nanostructure (YSN) with a mesoporous MnO2 shell and an Er3+-doped upconversion/downconversion nanoparticle (UCNP) core.
• To integrate diverse functional components for advanced cancer diagnosis and therapy.

Main Methods:

• Fabrication of YSNs with size-controllable hollow cavities and tunable MnO2 layers.
• Loading of guest molecules such as photosensitizers (methylene blue) and anticancer drugs (doxorubicin).
• Utilizing NIR-II fluorescence and photoacoustic imaging for tumor monitoring.

Main Results:

• Demonstrated successful synthesis of MnO2 YSNs integrating UCNPs, enabling size and layer thickness control.
• Showcased the loading capacity for various therapeutic agents.
• Confirmed TME-responsive degradation of MnO2 shell, generating Mn2+ for T1-MR imaging and releasing O2 and drugs.
• Achieved imaging-guided enhanced chemo-photodynamic therapy (PDT) with improved therapeutic efficacy.

Conclusions:

• The novel MnO2 YSNs offer a versatile platform for integrated cancer imaging and therapy.
• The unique structural features facilitate TME-responsive drug/O2 release and multimodal imaging.
• This imaging-guided combination therapy shows superior therapeutic effectiveness for malignant tumors compared to monotherapy.